Game Plan Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Game Plan Financial Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.74K	Hold	34	–	–	﹤0.01%	230
2025 Q4	$5.74K	Hold	34	–	–	﹤0.01%	234
2025 Q3	$4.91K	Sell	34 -20	-37%	-$2.73K	﹤0.01%	248
2025 Q2	$6.83K	Hold	54	–	–	﹤0.01%	238
2025 Q1	$6.91K	Hold	54	–	–	﹤0.01%	237
2024 Q4	$7.12K	Hold	54	–	–	﹤0.01%	243
2024 Q3	$7.86K	Hold	54	–	–	﹤0.01%	247
2024 Q2	$7.41K	Hold	54	–	–	﹤0.01%	251
2024 Q1	$7.41K	Hold	54	–	–	﹤0.01%	285
2023 Q4	$7.34K	Buy	+54	New	+$6.59K	﹤0.01%	269

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Game Plan Financial Advisors's IBB Position: Q1 2026 in Review

Game Plan Financial Advisors held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 34 shares worth $5.74K. The position accounts for ﹤0.01% of the portfolio, ranked #230.

Game Plan Financial Advisors first reported a position in IBB in Q4 2023 and has held it in 10 quarters since. The position peaked at $7.86K in Q3 2024. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Game Plan Financial Advisors held 34 shares of iShares Biotechnology ETF worth $5.74K as of Q1 2026.
Game Plan Financial Advisors left its iShares Biotechnology ETF share count unchanged in Q1 2026.
iShares Biotechnology ETF made up ﹤0.01% of Game Plan Financial Advisors's portfolio in Q1 2026, its #230 holding.
Game Plan Financial Advisors first reported a position in iShares Biotechnology ETF in Q4 2023 and has held it in 10 quarters since.
Game Plan Financial Advisors's iShares Biotechnology ETF position peaked at $7.86K in Q3 2024.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Game Plan Financial Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.